The tariff classification of Imatinib (CAS No. 152459-95-5) and Tofacitinib Citrate (CAS No. 540737-29-9) in bulk powder form, from Italy
Reasoning
The tariff classification of Imatinib (CAS No. 152459-95-5) and Tofacitinib Citrate (CAS No. 540737-29-9) in bulk powder form, from Italy
Cite this ruling
CBP Ruling N303161 (2933595300): The tariff classification of Imatinib (CAS No. 152459-95-5) and Tofacitinib Citrate (CAS No. 540737-29-9) in bulk powder form, from Italy
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 293359
The tariff classification of 6-Aminouracil (CAS 873-83-6) from China.
The tariff classification of 5-Aminouracil (CAS 932-52-5) from Canada.
The tariff classification of Zaleplon (CAS-151319-34-5), imported in bulk form, from China
The tariff classification of 1-Naphthalene-1-YL-Piperazine HCL (CAS 57536-86-4) from England.
The tariff classification of Tris(3-(Dimethylamino)Propyl)Hexahydro-1,3,5-Triazine (CAS 15875-13-5); 1,8-Diazabicyclo[5.4.0]undecene-7-Ene (CAS 6674-22-2); and 2,2-Dimorpholinodiethylether (CAS 6425-39-4) from China.